Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kotler Kevin
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   13    
Direct Shares   21,110,942    

Indirect Shares

   14,999,978      
Direct Value   $272,853,727    

Indirect Value

   $26,075,377      
Total Shares   36,110,920      
Total Value   $298,929,104      


Progenics Pharmaceuticals Inc $28,688,803 Societal CDMO, Inc $2,252,828 Travere Therapeutics, Inc $13,985,572 Strata Skin Sciences Inc $518,769 AVADEL Pharmaceuticals Plc $66,094,089 Mirati Therapeutics, Inc. $160,168,879 Novelion Therapeutics Inc $1,051,984 Heron Therapeutics Inc $92,804 Progenics Pharmaceuticals Inc $28,688,803 Societal CDMO, Inc $2,252,828 Travere Therapeutics, Inc $13,985,572 Strata Skin Sciences Inc $518,769 AVADEL Pharmaceuticals Plc $66,094,089 Mirati Therapeutics, Inc. $160,168,879 Novelion Therapeutics Inc $1,051,984 Heron Therapeutics Inc $92,804
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Progenics Pharmaceuticals Inc PGNX 10% Owner 2017-02-15 6,997,269 2014-07-16 0    Premium*  
            Societal CDMO, Inc SCTL 10% Owner 2018-05-24 2,048,025 2014-12-02 0    Premium*  
            Travere Therapeutics, Inc TVTX 10% Owner 2015-01-13 2,658,854 0    Premium*  
            Strata Skin Sciences Inc SSKN 10% Owner 2016-03-11 1,008,297 2015-08-11 1,274,297    Premium*  
            Dextera Surgical Inc DXTR 10% Owner 0 2015-09-04 8,874,992    Premium*  
            Aegerion Pharmaceuticals, Inc. AEGR 10% Owner 2016-11-29 0 2015-11-11 0    Premium*  
            AVADEL Pharmaceuticals Plc AVDL 10% Owner 2017-06-23 4,133,464 0    Premium*  
            Aratana Therapeutics, Inc. PETX 10% Owner 2019-07-18 0 0    Premium*  
            Corium International, Inc. CORI 10% Owner 2018-11-27 0 2017-10-04 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-16 2,728,601 2017-11-16 0    Premium*  
            Novelion Therapeutics Inc NVLN 10% Owner 2018-12-27 1,498,553 2018-12-24 0    Premium*  
            Biodelivery Sciences Internation... BDSI Director 2019-04-11 0 2020-03-17 4,310,689    Premium*  
            Heron Therapeutics Inc HRTX Director 2023-02-22 37,879 2023-02-22 540,000    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HRTX Heron Therapeutics Inc Director   –       •      –    2023-02-22 3 IO $0.00 $0 I/I 0 540,000 %
HRTX Heron Therapeutics Inc Director   –       •      –    2023-02-22 3 IO $0.00 $0 D/D 0 37,879 %
BDSI Biodelivery Sciences Inte... Director   –       •      –    2020-03-17 4 OE $2.93 $31,125 I/I 10,623 4,310,689 0 -
BDSI Biodelivery Sciences Inte... Director   –       •      –    2019-12-20 4 OE $1.80 $3,600,000 I/I 2,000,000 4,300,066 0 -
BDSI Biodelivery Sciences Inte... Director   –       •      –    2019-12-20 4 S $6.32 $6,320,000 I/I (1,000,000) 2,300,066 0 -
BDSI Biodelivery Sciences Inte... Director   –       •      –    2019-12-18 4 S $6.44 $6,485,000 I/I (1,000,000) 3,300,066 0 -
BDSI Biodelivery Sciences Inte... Director   –       •      –    2019-11-18 4 OE $1.80 $7,200,000 I/I 4,000,000 4,300,066 0 -
BDSI Biodelivery Sciences Inte... Director   –       •      –    2019-11-18 4 S $5.90 $10,584,165 I/I (1,793,757) 300,066 0 -
BDSI Biodelivery Sciences Inte... Director   –       •      –    2019-11-15 4 S $6.04 $13,319,089 I/I (2,206,243) 2,093,823 0 -
PETX Aratana Therapeutics, Inc... 10% Owner   –       –       •   2019-07-18 4 D $0.00 $0 D/D (7,258,135) 0 0 -
BDSI Biodelivery Sciences Inte... Director   –       •      –    2019-05-10 4 S $5.00 $9,000,000 I/I (1,800,000) 4,281,943 0 -
BDSI Biodelivery Sciences Inte... Director   –       •      –    2019-04-11 4 S $5.00 $10,000,000 I/I (2,000,000) 4,281,943 0 -
NVLN Novelion Therapeutics Inc 10% Owner   –       –       •   2018-12-27 4 S $0.85 $146,307 D/D (171,116) 1,498,553 0 -
NVLN Novelion Therapeutics Inc 10% Owner   –       –       •   2018-12-26 4 S $0.87 $254,715 D/D (278,485) 1,669,669 0 -
NVLN Novelion Therapeutics Inc 10% Owner   –       –       •   2018-12-24 4 S $0.98 $392 D/D (400) 1,948,154 0 -
CORI Corium International, Inc... 10% Owner   –       –       •   2018-11-27 4 D $0.00 $0 D/D (4,474,995) 0 0 -
SCTL Societal CDMO, Inc 10% Owner   –       –       •   2018-05-24 4 S $5.51 $1,093,182 D/D (188,000) 2,048,025 0 -
SCTL Societal CDMO, Inc 10% Owner   –       –       •   2018-03-13 4 S $10.07 $2,014,000 D/D (200,000) 2,236,025 0 -
SCTL Societal CDMO, Inc 10% Owner   –       –       •   2017-12-21 4 S $9.80 $500,240 D/D (51,000) 2,436,025 0 -
SCTL Societal CDMO, Inc 10% Owner   –       –       •   2017-12-20 4 S $10.00 $250,000 D/D (25,000) 2,487,025 0 -
SCTL Societal CDMO, Inc 10% Owner   –       –       •   2017-12-13 4 S $9.80 $178,139 D/D (18,137) 2,512,025 0 -
SCTL Societal CDMO, Inc 10% Owner   –       –       •   2017-12-12 4 S $9.80 $740,989 D/D (75,100) 2,530,162 0 -
SCTL Societal CDMO, Inc 10% Owner   –       –       •   2017-12-05 4 S $10.00 $1,000,000 D/D (100,000) 2,605,262 0 -
PETX Aratana Therapeutics, Inc... 10% Owner   –       –       •   2017-12-01 4 S $5.40 $3,059,350 D/D (562,428) 4,294,426 0 -
PETX Aratana Therapeutics, Inc... 10% Owner   –       –       •   2017-11-30 4 S $5.90 $1,256,591 D/D (211,572) 4,856,854 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us